Department of Periodontology, Dr. Harvansh Singh Judge Institute of Dental Sciences & Hospital, Panjab university, Chandigarh, Punjab, India.
Faculty of Dentistry, Meenakshi Academy of Higher Education and Research, Meenakshi Ammal Dental College and Hospital, Chennai, Tamil Nadu, India.
Clin Exp Dent Res. 2021 Aug;7(4):450-464. doi: 10.1002/cre2.386. Epub 2021 Jul 6.
Octenidine dihydrochloride is an antimicrobial cationic surfactant compound. We conducted a systematic review to determine the efficacy of octenidine-based mouthwash on plaque formation, gingivitis, and oral microbial growth in subjects with or without periodontal disease.
PubMed/MEDLINE, ScienceDirect, Google Scholar, and Cochrane Library were searched for relevant studies. The review was conducted per PRISMA guidelines. Only randomized controlled trials and observational studies comparing octenidine with placebo or other mouthwashes in healthy subjects with or without periodontal disease, were considered for this review. The endpoints included percentage reduction in plaque index (PI), gingival index (GI), absolute reduction in the mean number of colony-forming units (CFU/ml [log ]) and adverse effects (AEs; tooth staining/mucosal tolerance).
Ten randomized controlled and six observational studies fulfilled the selection criteria. Twice or thrice daily rinsing with 0.1% octenidine for 30-60 s produced significant reduction in plaque, gingivitis and oral microbial growth. Compared to control mouthwash or baseline, 0.1% octenidine inhibited plaque formation by ~38.7%-92.9%, which was either equal or greater than that of chlorhexidine gluconate. 0.1% octenidine reduced gingivitis by ~36.4%-68.37% versus control mouthwash or baseline and microbial growth by 0.37-5.3 colony-forming units (vs. chlorhexidine: 0.4-4.23 colony-forming units). Additional benefits of 0.1% octenidine were significant reduction in the number of bleeding sites, papilla bleeding index, sulcus bleeding index, and gingival fluid flow.
Within the limitations of this study, there exists moderate evidence that 0.1% OCT was found to be an effective antiplaque agent. Octenidine inhibited plaque formation upto 93% and gingivitis upto 68% versus placebo and was either superior or comparable to chlorhexidine. Octenidine was well-tolerated and safe and can be an effective alternative to CHX and other contemporary mouthwashes.
奥替尼啶二盐酸盐是一种抗菌阳离子表面活性剂化合物。我们进行了系统评价,以确定奥替尼啶基漱口水在患有或不患有牙周病的受试者中对牙菌斑形成、牙龈炎和口腔微生物生长的疗效。
在 PubMed/MEDLINE、ScienceDirect、Google Scholar 和 Cochrane Library 上搜索相关研究。本综述按照 PRISMA 指南进行。仅纳入比较奥替尼啶与安慰剂或其他漱口水在患有或不患有牙周病的健康受试者中的随机对照试验和观察性研究。终点包括菌斑指数(PI)、牙龈指数(GI)减少百分比、平均菌落形成单位数(CFU/ml [log])绝对减少和不良反应(AE;牙齿染色/黏膜耐受性)。
符合选择标准的有 10 项随机对照试验和 6 项观察性研究。每天两次或三次用 0.1%奥替尼啶冲洗 30-60 秒可显著减少牙菌斑、牙龈炎和口腔微生物生长。与对照漱口水或基线相比,0.1%奥替尼啶抑制菌斑形成的效果约为 38.7%-92.9%,与洗必泰葡萄糖酸相比,其效果要么相等,要么更大。0.1%奥替尼啶使牙龈炎减少约 36.4%-68.37%,与对照漱口水或基线相比,使微生物生长减少 0.37-5.3 个菌落形成单位(与洗必泰相比:0.4-4.23 个菌落形成单位)。0.1%奥替尼啶的其他益处包括显著减少出血部位、乳头出血指数、龈沟出血指数和牙龈液流量。
在本研究的限制范围内,有中等证据表明 0.1% OCT 被发现是一种有效的抗菌斑剂。奥替尼啶抑制菌斑形成的效果高达 93%,牙龈炎的效果高达 68%,与安慰剂相比,效果要么更好,要么与洗必泰相当。奥替尼啶耐受性良好且安全,可作为洗必泰及其他当代漱口水的有效替代品。